KRAS and cancer: When we inhibited GSK3 with SB treatment, c-Myc levels were substantially increased within 4 h of treatment, and this coupled with the gene knockout results of Fig. 6, suggest that c-Myc was necessary for SB to induce apoptosis in mutant KRas-dependent human cancer cells.